Shreya Agarwal/LInkedIn
Oct 17, 2025, 06:38
Not All Thrombotic Microangiopathies Behave the Same – Published in RPTH
RPTH Journal posted on LinkedIn:
”Not all thrombotic microangiopathies (TMAs) behave the same, and they don’t all respond to complement blockade.
In a new study, Shreya Agarwal and team describe a subset of patients with plasminogen (PLG) mutations who experienced recurrent TMA despite standard therapy. Their response to anticoagulation hints at an alternative disease pathway worth exploring.
Coauthors: Nicola Pozzi; Senthil Sukumar, Camila Masias, Anuja Java, Spero Cataland”
Read the full article here.
Title: Plasminogen mutation–associated thrombotic microangiopathy and role of anticoagulation: a single institution case series
Stay updated with Hemostasis Today.
-
Nov 2, 2026, 10:18Salih Ehsan: Beyond IRIDA – Conditions That Mimic Iron-Refractory Anemia
-
Nov 2, 2026, 10:03Christian Heiss: Can Switching to E-Cigarettes Improve Vascular Health?
-
Nov 2, 2026, 09:56Priya Prasad: Safe Blood Begins with Informed Choices
-
Nov 2, 2026, 09:43Moath Ahmad Albliwi: More Than 10 Abstracts Accepted for ASH 2026
-
Nov 2, 2026, 02:56Leonhard Stärk: The Future of Universal Donor-Free Red Blood Cells
-
Nov 2, 2026, 02:45Marija Tashkovska: Advancing Transfusion Medicine Through Collaboration
-
Nov 2, 2026, 02:32Rachel Rosovsky: Pulmonary Embolism During Pregnancy and Postpartum
-
Nov 2, 2026, 02:26Jaromir Vajter: Bleeding Risks and Anticoagulation After ECPR
-
Nov 2, 2026, 02:13Maia Meier: 111 Kilometres on Skis to the South Pole